Clinical Trials & REMS in the Time of Corona: FDA & MHRA Advice and Guidance

/ Apr 09, 2020

Pharmacovigilance expert Bart Cobert discusses the FDA and MHRA guidance for non-Corona related clinical trials.

Read More

Does Rapid FDA Approval Produce Drug Safety Issues?

/ Mar 16, 2020

Bart Cobert gives his pharmacovigilance point of view on a recent paper on FDA approval timelines and drug safety issues.

Read More

Pharmacovigilance 2030

/ Dec 11, 2019

This is an interesting article looking at what PV will be in the year 2030.

Read More

FDA Draft Guidance on PMRs

/ Nov 24, 2019

Bart Cobert highlights the most important changes in the recently revised FDA draft guidance on PMRs.

Read More

Vaping – A Serious Safety Signal

/ Oct 07, 2019

Bart Cobert discusses the major safety issue in the US on e-cigarettes and vaping.

Read More

Importing Canadian Drugs to the US

/ Aug 29, 2019

Bart Cobert covers several issues involved in setting up the proposed "Safe Importation Plan" which aims to allow US consumers to get safe and cheaper drugs.

Read More

No-No’s in Drug Safety

/ Aug 13, 2019

An overview covering a number of things to avoid doing when it comes to drug safety.

Read More

Different Regulatory Actions from Different Agencies

/ Jun 27, 2019

Bart Cobert explores the potential reasons for the differing regulatory actions from the different agencies.

Read More

Contributions of Nurses in Pharmacovigilance and Drug Safety

/ Jun 24, 2019

Dr. Adele Mueller explores the strong patient safety and advocacy responsibility of nurses who work in the pharmaceutical industry.

Read More

Reporting and Not Reporting Data

/ Jun 03, 2019

Bart Cobert discusses the importance of clinical safety reporting. Not only is this a legal responsibility but also an ethical one.

Read More

Blog Signup